Relation is an England-based active-graph machine learning platform that provides drug discovery and development solutions for the pharmaceutical sector.
$15M
Nov 21, 2024
-
Elegen is a California-based SaaS platform that provides solutions such as DNA production and clinical manufacturing for the pharmaceutical sector.
$35M
May 14, 2024
-
BioVersys is a Switzerland-based clinical-stage biopharmaceutical company that develops small-molecule therapeutics for the treatment of nosocomial infections.
$13.6M
May 06, 2024
-
Sitryx is an England-based biopharmaceutical company that researches and develops immune cell metabolism therapies for the treatment of chronic autoimmune diseases and cancer.
$39M
Sep 26, 2023
-
Frequently Asked Questions about GSK
What is GSK investing in?
GSK has invested in 27 companies including Ouro Medicines, Relation and Elegen
What company did GSK invest in?
GSK invested in a total 27 companies including Ouro Medicines, Relation and Elegen
What are the top 5 investments by GSK?
The top companies in which GSK invested are Ouro Medicines, Relation, Elegen, BioVersys and Sitryx
